Physician

Mark T Edney, MD

According to 2025 Medicare claims, Mark Edney, MD (NPI: 1184684789) practices urology in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is CHESAPEAKE UROLOGY ASSOCIATES, LLC (NPI: 1194147835; TIN: 522146172) and primary practice location at 21804-5109.

Edney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,295 traditional Medicare patients, billed 12,519 HCPCS/CPT codes, and received $257,858 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,255 prescription claims across 350 beneficiaries totaling $609,499 in drug costs, led by Erleada (Apalutamide). DME data shows 98 claims. Open Payments data shows 34 records totaling $1,251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $104,885 and ending at $609,499. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $336 and ending at $1,431.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,669	4,910	$305,307
2016	1,666	5,660	$334,722
2017	1,562	4,385	$301,387
2018	1,385	4,094	$297,739
2019	1,495	7,224	$322,989
2020	1,287	8,354	$469,672
2021	1,298	6,708	$358,727
2022	1,173	6,420	$275,433
2023	1,183	4,071	$212,705
2024	1,295	12,519	$257,858

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	809	$104,885
2016	229	691	$46,624
2017	280	847	$64,338
2018	337	1,049	$93,104
2019	302	1,113	$101,347
2020	272	1,106	$94,783
2021	256	976	$73,787
2022	253	907	$83,223
2023	292	1,054	$92,852
2024	350	1,255	$609,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	160	$23,876
2016	26	161	$25,288
2017	43	213	$29,998
2018	23	143	$18,739
2019	22	204	$37,142
2020	18	215	$45,251
2021	24	217	$51,713
2022	20	216	$82,980
2023	29	175	$87,415
2024	15	98	$68,666

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	461	562	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	388	432	$59
52000	Diagnostic exam of bladder and urethra using an endoscope	214	225	$58
76775	Limited ultrasound scan behind abdominal cavity	248	256	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	788	1,034	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	20	600	$279,482
Xtandi	Enzalutamide	12	360	$170,414
Orgovyx	Relugolix	21	630	$55,051
Gemtesa	Vibegron	59	2,470	$37,652
Myrbetriq	Mirabegron	35	2,010	$28,694

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	30	$51,097
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	15	68	$17,570

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$1,251	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark T. Edney, MD?

Tedicare shows public-source Medicare data for Mark T. Edney, MD (NPI 1184684789), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark T. Edney, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark T. Edney, MD?

Mark T. Edney, MD is linked to CHESAPEAKE UROLOGY ASSOCIATES, LLC (billing NPI 1194147835) in the available physician profile data.

Does Mark T. Edney, MD have Open Payments data?

Mark T. Edney, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.